{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464387412
| IUPAC_name =  
| image =  
<!-- Clinical data -->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = B01
| ATC_suffix = AD08
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = U5NH2JV64T
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Saruplase''' is a [[fibrinolytic]] enzyme.<ref name="pmid10608024">{{cite journal  |vauthors=Bär FW, Vermeer F, Michels R, etal |title=Saruplase in Myocardial Infarction |journal=J. Thromb. Thrombolysis |volume=2 |issue=3 |pages=195–204 |year=1995 |pmid=10608024 |doi= |url=}}</ref>

It is closely related to [[urokinase]].<ref name="pmid15992082">{{cite journal |vauthors=Moser M, Bode C |title=Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction |journal=Expert Opin Investig Drugs |volume=8 |issue=3 |pages=329–35 |date=March 1999 |pmid=15992082 |doi=10.1517/13543784.8.3.329 |url=}}</ref>

==References==
{{reflist}}

==External links==
* {{MeshName|Saruplase}}

{{Antithrombotics}}

[[Category:Antithrombotic enzymes]]


{{blood-drug-stub}}